期刊文献+

血浆D-二聚体检测及其对心房颤动患者血栓诊断的研究进展 被引量:6

The Latest Development of Detection of Plasma D-dimer and Its Significance in Diagnosis of Thrombi in Atrial Fibrillation
下载PDF
导出
摘要 血浆D-二聚体是纤溶酶水解交联纤维蛋白形成的降解产物之一,为继发性纤溶特有的代谢物,其含量变化可作为体内高凝状态和原发性与继发性纤溶鉴别的可靠指标,也可作为溶栓治疗有效性的观察指标。近年来,D-二聚体检测在临床得到新的应用,尤其对心房颤动患者血栓的诊断。现就血浆D-二聚体检测及其对心房颤动患者血栓诊断的研究进展予以综述。 Plasma D-dimer is one of the degradation products of the cross-linked fibrin hydrolyzed by fibrinolysin and is also a unique metabolite of secondary fibrolysis. The change of its content is a reliable indicator for the identification of the hypercoagulabale state in vivo and primary and secondary fibrinolysis, as well as for the observation of the effectiveness of thrombolytic therapy. In recent years, D-dimer determination has new clinical applications, especially in diagnosis of thrombi in atrial fibrillation. Here is to make a review on the research progress of D-dimer detection and its diagnosis value for thrombus in atrial fibrillation patients.
出处 《医学综述》 2012年第5期726-729,共4页 Medical Recapitulate
关键词 D-二聚体 心房颤动 检测方法 D-dimer Atrial fibrillation Detection method
  • 相关文献

参考文献25

  • 1Kearon C,Ginsberg JS,Douketis J,et al.An evaluation of D-dimer in the diagnosis of pulmonary embolism:a randomized trial[J].Ann Intern Med,2006,144(11):812-821.
  • 2翁晓峰.血浆中D-二聚体正常参考值范围的探讨[J].职业与健康,2010,26(7):765-766. 被引量:5
  • 3曹玉静,王纪刚.血浆D-二聚体的测定方法及临床应用[J].临床和实验医学杂志,2010,9(19):1514-1515. 被引量:10
  • 4Albers GW,Amarenco P,Easton JD,et al.Antithrombotic and thrombolytic therapy for ischemic stroke:American College of Chest Physicians Evidence Based Clinical Practice Guidelines[J].Chest,2008,133(6 Suppl):630S-669S.
  • 5Waldo AL.Anticoagulation:stroke prevention in patients with atrial fibrillation[J].Cardiol Clin,2009,27(1):125-135.
  • 6Orsinelli DA.Current recommendations for the anti-coagulation of patients with atrial fibrillation[J].Prog Cardiovasc Dis,1996,39(1):1-20.
  • 7张琪,车琳,陈晓光.心房颤动与缺血性脑卒中的关系[J].黑龙江医学,2010,34(4):257-259. 被引量:10
  • 8Conway DS,Pearce LA,Chin BS,et al.Prognostic value of plasmavonWille brand factor and soluble P-select in as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation[J].Circulation,2003,107(25):3141-3145.
  • 9Rahimi AR,Wrights B,Akhondi H,et al.Clinical correlation between effective anticoagulants and risk of stroke:are we using evidence-based strategies?[J].South Med J,2004,97(10):924-931.
  • 10Boos CJ,More RS.Anticoagulation for non-valvular atrial fibrillation towards a new beginning with ximelagatran[J].Curr Control Trials Cardiovasc Med,2004,5(1):3.

二级参考文献56

共引文献41

同被引文献67

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部